P
ELAN icon

&Partners’s Elanco Animal Health ELAN Stock Holding History

&Partners’s Portfolio ELAN Stock Details ELAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$737K Sell
29,984
-1,893
-6% -$43.8K ﹤0.01% 1608
2026
Q1 		$763K Buy
31,877
+7,370
+30% +$180K ﹤0.01% 1455
2025
Q4 		$555K Sell
24,507
-4,005
-14% -$87.2K ﹤0.01% 1550
2025
Q3 		$573K Buy
28,512
+399
+1% +$6.68K ﹤0.01% 1375
2025
Q2 		$400K Buy
28,113
+3,468
+14% +$40.5K ﹤0.01% 1459
2025
Q1 		$260K Buy
24,645
+14,147
+135% +$160K ﹤0.01% 1484
2024
Q4 		$126K Buy
+10,498
New +$137K ﹤0.01% 1589

Other funds holding ELAN

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

&Partners's ELAN Position: Q2 2026 in Review

&Partners reduced its Elanco Animal Health (ELAN) stake by 5.9% in Q2 2026, selling an estimated $43.8K and leaving 29,984 shares worth $737K. The position accounts for ﹤0.01% of the portfolio, ranked #1608.

&Partners first reported a position in ELAN in Q4 2024 and has held it in 7 quarters since. The position peaked at $763K in Q1 2026. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • &Partners held 29,984 shares of Elanco Animal Health worth $737K as of Q2 2026.
  • &Partners sold 1,893 Elanco Animal Health shares in Q2 2026, an estimated $43.8K.
  • Elanco Animal Health made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1608 holding.
  • &Partners first reported a position in Elanco Animal Health in Q4 2024 and has held it in 7 quarters since.
  • &Partners's Elanco Animal Health position peaked at $763K in Q1 2026.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.